Intellectual property rights, especially patents, frequently form the foundation of value in a life sciences company. If conducted with eventual commercial success in mind, a due diligence review of an IP portfolio can enable an investor to assess more accurately the present and future value of the technology and IP associated with an investment. Often times however, little thought is given as to how to leverage the harvested intelligence in the commercialization process of the acquired technology after the deal. This panel discussed:
- The IP due diligence process – what to expect and preparing for the unexpected
- Working the IP – identifying and valuing know-how to execute the IP
- The technology factor – working with R & D during and after the diligence process
Related Insights
27 May 2025
Events
The RIF Roadmap: Tools and Tactics for a Smooth and Compliant Transition
Join us for an insightful discussion on proactive workforce planning in today's dynamic economic and regulatory landscape.
16 May 2025
Manufacturing Industry Advisor
Reese’s Law: The Evolving Regulatory and Enforcement Landscape for Consumer Products Containing Button Cell or Coin Batteries
Over the past year, manufacturers, importers, distributors, and retailers of consumer products containing button cell and coin batteries (or products intended to contain them) have continued to adapt to the requirements of Reese’s Law and the Consumer Product Safety Commission’s corresponding enforcement efforts.
29 May 2025
Events
May 2025 Midwest Cyber Security Alliance Meeting | What Happens After a Breach: Practical Tips for the Notification Process
Join us on Thursday, May 29, 2025, at the next Midwest Cyber Security Alliance Meeting. Brandon Hollinder, Esq., and Adam Botter from Epiq will provide practical tips and insights on organizing the data mining and subsequent notification process after a cybersecurity breach.